Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tejnaksh HealthcareBOM:539428 -1.72%72 Gross Margin % is 91.36% as of Mar. 2026, which is 1% above its 10-year median of 90.29. GuruFocus rates BOM:539428 with a GF Score™ of 72/100 and a GF Value™ of ₹20.94 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Tejnaksh Healthcare ranks better than 93.95% on this metric.
The historical rank and industry rank for Tejnaksh Healthcare's Gross Margin % or its related term are showing as below:
BOM:539428'
s Gross Margin % Range Over the Past 10 Years
Min: 87.72 Med: 90.29 Max: 93.85
Current: 90.56
During the past 12 years, the highestGross Margin % of Tejnaksh Healthcare was 93.85%. The lowest was 87.72%. And the median was 90.29%.
BOM:539428's Gross Margin % is ranked better than 93.95% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs BOM:539428: 90.56
Tejnaksh Healthcare had a gross margin of 91.36% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Tejnaksh Healthcare was -0.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Tejnaksh Healthcare had a gross margin of 91.36% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Tejnaksh Healthcare Gross Margin % Related Terms
Tejnaksh Healthcare Gross Margin % Historical Data
* Premium members only.
The historical data trend for Tejnaksh Healthcare's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539428 vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Tejnaksh Healthcare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tejnaksh Healthcare Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tejnaksh Healthcare's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Tejnaksh Healthcare's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Tejnaksh Healthcare (BOM:539428) has a Gross Margin % of 91.36% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Tejnaksh Healthcare and its competitors. This is near median its historical median of 90.29. Over the past decade, Tejnaksh Healthcare's Gross Margin % has ranged from 87.72 to 93.85. According to the industry distribution chart, Tejnaksh Healthcare ranks #38 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 6.1%.
Is Tejnaksh Healthcare's Gross Margin % too high?
Tejnaksh Healthcare's current Gross Margin % of 91.36% is near median its 10-year median of 90.29. Over the past 10 years, this metric has ranged from a low of 87.72 to a high of 93.85. The Healthcare Providers & Services industry median Gross Margin % is 40.08. Tejnaksh Healthcare's value of 91.36% is 128% above this industry median. Based on the distribution chart, Tejnaksh Healthcare ranks #38 out of 628 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Tejnaksh Healthcare has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tejnaksh Healthcare's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tejnaksh Healthcare ranks #38 out of 628 companies for Gross Margin %. This places Tejnaksh Healthcare in the top 6% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.08. Tejnaksh Healthcare's value of 91.36% is 128% above this benchmark. Historically, Tejnaksh Healthcare's own Gross Margin % has ranged from 87.72 to 93.85 over the past decade. While the company's 10-year median is 90.29 vs. the industry median of 40.08, Tejnaksh Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tejnaksh Healthcare's current Gross Margin % of 91.36% is 128% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Tejnaksh Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tejnaksh Healthcare's current Gross Margin % is 91.36%, which is near median its own 10-year median of 90.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tejnaksh Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Tejnaksh Healthcare (BOM:539428) is currently considered Possible Value Trap. The stock's GF Value™ is ₹20.94, compared to a current price of ₹13.72 — trading 34.5% below its estimated fair value. The current Gross Margin % is 91.36%, which is near median its 10-year median of 90.29 and 128% above the Healthcare Providers & Services industry median of 40.08. Tejnaksh Healthcare's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Tejnaksh Healthcare (BOM:539428), the current Gross Margin % is 91.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?
Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued.
The current stock price of ₹13.72 is trading 34.5% below its estimated GF Value™ of ₹20.94.
GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.
Key valuation signals for BOM:539428:
Gross Margin %: 91.36% (near median its 10-year median of 90.29)
GF Value™: ₹20.94 vs. price of ₹13.72 (34.5% below fair value)
Industry Position: 128% above the Healthcare Providers & Services median (#38 of 628)
No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
72GF Score
Get the complete analysis for BOM:539428
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539428 has been successfully added to your 
